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Abstract: Chronic wounds like venous calf and diabetic foot ulcers are frequently contaminated and colonized by bacteria and
it remains unclear whether there is sufficient expression of defensins and recruitment of epidermal Langerhans cells in the
margin of ulcer compared to normal skin. The aim of this study was to examine immunohistochemically the expression of
β-defensin-2 (hBD2), GM-CSF, VEGF growth factors and accumulation of CD1a+ Langerhans cells (LC) in epidermis from
chronic skin ulcers and to compare it to normal skin from the corresponding areas. Studies were carried out in 10 patients with
diabetic foot, 10 patients with varicous ulcers of the calf and 10 patients undergoing orthopedic surgery (normal skin for
control). Biopsy specimens were immunostained using specific primary antibodies, LSAB+ kit based on biotin-avidin-
peroxidase complex technique and DAB chromogen. Results were expressed as a mean staining intensity. Statistical analysis
of staining showed significantly higher staining of hBD2 in both normal and ulcerated epidermis from foot sole skin compared
to calf skin (normal and ulcerated, p<0.05). Chronic ulcers showed the same expression of hBD2 as normal skin. There was
significantly lower accumulation of CD1a+ LC in normal epidermis from foot sole skin compared to normal calf skin (p<0.05).
Accumulation of CD1a+ LC and GM-CSF upregulation at the border area of diabetic foot ulcer and reduction of LC
concentration at the margin of venous calf ulcer compared to normal skin were observed. It seems that normal calf and sole
epidermis is, unlike in the mechanisms of innate immunity, influenced by the different keratinocyte turnover and bacterial flora
colonizing these regions. Insufficient upregulation of hBD2 in both diabetic foot and venous calf ulcers may suggest the
pathological role of this protein in the chronicity of ulcers.
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Introduction
Skin is an active immune organ and its injury and
microbial invasion trigger the activity of two important
components of its innate immunity, namely epidermal
dendritic cells (Langerhans cells) and antimicrobial pep-
tides (AMPs). The latter natural antibiotics with broad
activity against bacteria, fungi and enveloped viruses
participate in the epithelial innate immune processes and
are used as the first line of immune defence. AMPs are
divided into several categories on the basis of their
structure. In humans two major families of AMPs have
been characterized: defensins (α and β) and cathelici-
dins. They were isolated from granules of human periph-
eral blood neutrophils as well as from macrophages,
epithelial cells of the alimentary, respiratory and uro-
genital systems, and skin epidermis [8, 15]. Skin kerati-
nocytes express three β-defensins: human β-defensin-1,
-2, -3 (hBD1, 2, 3). In normal human skin, hBD1 is
produced constitutively. In vitro, hBD2 synthesis is
upregulated in keratinocytes by contact with microor-
ganisms such as E.coli, Staphylococcus epidermidis and
aureus and Candida albicans [1, 3, 6, 9, 12]. IL1 and
IL6 enhance the epidermal antimicrobial response [5].
The hBD2 may also participate in other aspects of innate
antimicrobial immunity since it chemoattracts mono-
cytes and immature dendritic cells [4, 14]. Other factors,
such as granulocyte-macrophage colony stimulating
factor (GM-CSF) and vascular endothelial growth factor
(VEGF) are also critical for dendritic cell recruitment in
vivo and differentiation in vitro [7, 11]. Chronic wounds
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like venous leg and diabetic foot ulcers are frequently
contaminated and colonized by bacteria and one may ask
the question as to whether there is sufficient expression of
defensins and accumulation of epidermal Langerhans cells
(LC) in the margin of ulcer compared to normal skin.
The aim of the present study was to examine immu-
nohistochemically the expression of hBD2, GM-CSF
and VEGF as well as LC accumulation in epidermis of
chronic skin ulcers, compared to normal skin from the
corresponding areas. 
Materials and methods
Patients. The biopsy material investigated in this study originated
from (1) ten patients, mean age 62 years, with type 2 diabetes
complicated by foot ulcers grade 2-4 according to Wagner’s classi-
fication of 3 to 6 months duration, (2) ten patients, mean age 67 years,
with varicous ulcers of the calf of more than one year duration, and
(3) eight nondiabetic patients, mean age 62 years, undergoing elec-
tive orthopedic surgery, providing control skin. All patients were
treated in a uniform fashion with hydrocolloid dressings. At the time
the biopsies were taken, no signs of inflammation were seen around
the ulcers. Also no significant numbers of isolates were cultured from
the bottom of ulcers. Occasionally, simple colonies of Proteus and
Staphylococcus aureus were identified. This study was approved by
the Ethical Committee of the Medical Research Center, Warsaw,
Poland.
Skin biopsies. Skin biopsies were obtained under local anesthesia
with 2% lignocaine from the border area of leg ulcers and from the
topographically corresponding sites of normal subjects undergoing
surgery for fracture correction. Two rectangles of tissue approxi-
mately 10 mm in length and 3 mm wide, comprising the ulcer edge
and surrounding skin were excised and one specimen was snap
frozen in a dry ice-cold acetone and stored at -70˚C, whereas the other
one was fixed in 4% phosphate buffered formalin and embedded in
paraffin. The paraffin-embedded specimens were cut into 4 μm
sections and placed on silane-coated glass slides (Dako, Gloustrup,
Denmark). Frozen serial sections 4 μm thick mounted on poly-L-ly-
sine (Sigma, Pool, UK) coated glass slides were dried at room
temperature (RT) overnight and stored at -20˚C.
Antibodies and immunohistochemistry. The specific primary anti-
bodies against the following antigens were applied (code number and
working solution in parentheses): human β-defensin-2 (sc-10854,
1/200) from Santa Cruz Biotech (Santa Cruz, Ca); CD1a (M721,
1/50), HLA-DR (M746, 1/30) from Dako (Glostrup, Denmark);
GM-CSF (AB-215-NA, 1/50) and VEGF (AB-293-NA, 1/50) from
R&D Systems (Abingdon, United Kingdom). The paraffin-em-
bedded sections used for staining with anti-VEGF antibody were
deparaffinized at 57˚C for 15 min and then dewaxed in xylene, taken
through graded ethanol and rehydrated in TBS (TRIS-buffered
saline). They were boiled two times for 5 min in 0.01 M sodium
citrate in microwave oven and after washing blocked with 50%
normal swine serum for 20 min. The frozen sections were allowed
to thaw at RT before being unwrapped and then they were fixed in
cold acetone for 10 min at RT. To remove endogenous peroxidase
activity, all slides were incubated in 3% H2O2 for 5 min and washed
in TBS. Tissue sections were incubated with primary antibodies
diluted in TBS for 30 min (CD1a, HLA-DR, GM-CSF) or 60 min at
RT (anti-defensin) or overnight at 4˚C (VEGF). Control sections
were processed parallelly without the primary antibody. A standard
labelling technique using avidin-biotin-immunoperoxidase complex
(Dako) was employed (LSAB2 kit for mouse and rabbit immunoglo-
bulins and LSAB+ kit for goat globulins and paraffin-embedded
sections). Sections were processed simultaneously for all antigens
according to the procedure outlined by the manufacturer. Each
incubation step was 18 min with 5 min washes inbetween. Color
reaction was performed with DAB (Sigma Chemical Co, St Louis,
USA) substrate for 5 min. Finally, the sections were counterstained
with 0.2% Mayers hematoxylin (Sigma) for 1 min. Frozen sections
were mounted in glycergel (Dako) and paraffin embedded ones in
Canada balsam (Fluka Chemie AG, Buchs, Switzerland). 
The staining assessment. The mean staining intensity of hBD2,
HLA-DR, GM-CSF, VEGF and CD1a was assessed semi-quantita-
tively using a score system: 0 = no staining; 1 = weak staining; 2 =
moderate staining; 3 = strong staining. All samples were evaluated
microscopically by two study-blinded investigators. The two scores
of three serial tissue sections were averaged for each specimen and
these averaged values were used for comparisons.
Data analysis. The Monte Carlo exact test was used to investigate
the significance of differences in the mean intensities of staining
between studied groups. P-value <0.05 was considered statistically
significant.
Results and discussion
The immunostaining demonstrated a variable express-
ion of hBD2 and accumulation of CD1a+ LC in epider-
mis depending on the area (Fig. 1). There was a
Fig. 1. The mean staining intensity
of hBD2, VEGF, GM-CSF in kerati-
nocytes and of CD1a, HLA-DR in
Langerhans cells in regenerating
epidermis of venous and diabetic
foot ulcers and topographically
corresponding contro l skin
(*p<0.05 venous or diabetic vs. nor-
mal; **p<0.05 calf vs. foot).
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Fig. 2. Immunostaining of hBD2 (a-d), CD1a+ Langerhans cells (e-h) and GM-CSF (i-l) in epidermis at the border area of diabetic foot (a,
e, i) and venous calf (c, g, k) ulcers and in normal foot (b, f, j) and calf (d, h, l) skin. b,e,f,i,j: × 100, a,c,d,g,h,k,l: × 200.
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significantly enhanced staining intensity of hBD2 in
keratinocytes of both normal and ulcerated epidermis
from foot sole skin compared to the weak staining of calf
skin (normal and ulcerated, p<0.05), (Fig. 2 a-d). Stain-
ing was localized mainly in stratum corneum and in the
interkeratinocyte space of the Malpighian layer. In con-
trast, there was a significantly reduced concentration of
CD1a+ LC in normal epidermis from foot sole skin
compared to normal skin of calf (p<0.05), (Fig. 2 e-h).
We observed the reduced expression of CD1a marker at
the edge of venous calf ulcers (p<0.05) compared to
control skin and significantly increased expression of
both CD1a and HLA-DR markers of LC on the margin
of diabetic foot ulcer compared to normal sole skin
(p<0.05). In contrast to lack of GM-CSF staining in
normal sole epidermis, keratinocytes at the border of
diabetic foot ulcer expressed GM-CSF (p<0.05), (Fig. 2
i-l). The intensity of this staining was significantly
higher than that observed in calf epidermis. All studied
epidermal samples revealed a comparable, moderate to
strong, expression of VEGF (Fig.1).
Our results are consistent with previous reports that
hBD2 is detectable in normal human skin and that sole
skin demonstrates intense immunostaining [1]. Low ex-
pression of hBD2 in calf epidermis in contrast to sole
skin may reflect differences in keratinocyte turnover
[10] or bacterial colonization. Production of hBD2 can
be activated in keratinocytes by IL1β [13] in vitro and
by wounding of normal skin [2]. However, no upregu-
lation of hBD2 immunostaining compared to normal
skin was observed by us in the chronic ulceration, both
in venous calf and diabetic foot ulcers. This can suggest
that insufficient expression of hBD2 may play a pa-
thogenic role in chronic wounds.
Moreover, we demonstrated a variable accumulation
of epidermal CD1a+ LC depending on the leg area, low
in sole and enhanced in calf. The observed high level of
LC in diabetic foot ulcer could be associated with sim-
ultaneously enhanced expression of GM-CSF, a growth
factor critical for dendritic cell survival and differentia-
tion [11]. Other factors, hBD2 and VEGF, supposed to
influence dendritic cell accumulation [14] or reduction
in skin [7] appeared not to be correlated with expression
of epidermal CD1a marker in diabetes. 
We suggest that normal calf and sole epidermis are,
unlike as in the mechanisms of innate immunity, in-
fluenced by the different keratinocyte turnover and bac-
terial flora colonizing these regions. Chronic wounds,
both diabetic foot and varicous calf ulcers, showed in-
sufficient expression of hBD2 as compared to normal
skin suggesting the pathological role of this protein in
chronicity of ulcers. 
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